SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.31 revenue of $2.9M February, 11 2022 04:42 PM Sonoma Pharmaceuticals Inc. Sonoma Pharmaceuticals press release (NASDAQ:SNOA): FQ3 GAAP EPS of -$0.31. Revenue of $2.9M (-41.3% Y/Y). For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.31, revenue of $2.9M